Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome

Alexis Lizarraga, Karlo J. Lizarraga, Michael G Benatar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

After prompt diagnosis, severe myasthenia gravis and Guillain-Barré syndrome (GBS) usually require management in the intensive care unit. In the myasthenic patient, recognition of precipitating factors is paramount, and frequent monitoring of bulbar, upper airway, and/or respiratory muscle strength is needed to identify impending myasthenic crisis. Noninvasive ventilation can be attempted prior to intubation and mechanical ventilation in the setting of respiratory failure. Cholinesterase inhibitors should be discontinued, but resumed prior to extubation, and steroid dosage could be increased once the airway is secured. In GBS, hemodynamic and respiratory monitoring are essential; however, respiratory failure can develop rapidly and intubation with mechanical ventilation is often required and can be prolonged. Guillain-Barré syndrome can also be complicated by dysautonomia necessitating specific therapies. Prompt recognition and initiation of immunotherapy including intravenous immunoglobulin or plasmapheresis, together with supportive care including treatment of underlying infections and physical therapy, can improve outcomes in both myasthenic crisis and GBS.

Original languageEnglish (US)
Pages (from-to)615-624
Number of pages10
JournalSeminars in Neurology
Volume36
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Myasthenia Gravis
Muscle Weakness
Artificial Respiration
Intubation
Respiratory Insufficiency
Primary Dysautonomias
Noninvasive Ventilation
Precipitating Factors
Respiratory Muscles
Plasmapheresis
Intravenous Immunoglobulins
Cholinesterase Inhibitors
Muscle Strength
Immunotherapy
Intensive Care Units
Therapeutics
Hemodynamics
Steroids
Infection

Keywords

  • acute inflammatory demyelinating polyradiculo-neuropathy
  • Guillain-Barré syndrome
  • myasthenia gravis
  • myasthenic crisis
  • neurocritical care

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Getting Rid of Weakness in the ICU : An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome. / Lizarraga, Alexis; Lizarraga, Karlo J.; Benatar, Michael G.

In: Seminars in Neurology, Vol. 36, No. 6, 01.12.2016, p. 615-624.

Research output: Contribution to journalArticle

@article{ffaa6fdb5f6d4222915045aaa0f50c0a,
title = "Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barr{\'e} Syndrome",
abstract = "After prompt diagnosis, severe myasthenia gravis and Guillain-Barr{\'e} syndrome (GBS) usually require management in the intensive care unit. In the myasthenic patient, recognition of precipitating factors is paramount, and frequent monitoring of bulbar, upper airway, and/or respiratory muscle strength is needed to identify impending myasthenic crisis. Noninvasive ventilation can be attempted prior to intubation and mechanical ventilation in the setting of respiratory failure. Cholinesterase inhibitors should be discontinued, but resumed prior to extubation, and steroid dosage could be increased once the airway is secured. In GBS, hemodynamic and respiratory monitoring are essential; however, respiratory failure can develop rapidly and intubation with mechanical ventilation is often required and can be prolonged. Guillain-Barr{\'e} syndrome can also be complicated by dysautonomia necessitating specific therapies. Prompt recognition and initiation of immunotherapy including intravenous immunoglobulin or plasmapheresis, together with supportive care including treatment of underlying infections and physical therapy, can improve outcomes in both myasthenic crisis and GBS.",
keywords = "acute inflammatory demyelinating polyradiculo-neuropathy, Guillain-Barr{\'e} syndrome, myasthenia gravis, myasthenic crisis, neurocritical care",
author = "Alexis Lizarraga and Lizarraga, {Karlo J.} and Benatar, {Michael G}",
year = "2016",
month = "12",
day = "1",
doi = "10.1055/s-0036-1592106",
language = "English (US)",
volume = "36",
pages = "615--624",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Getting Rid of Weakness in the ICU

T2 - An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome

AU - Lizarraga, Alexis

AU - Lizarraga, Karlo J.

AU - Benatar, Michael G

PY - 2016/12/1

Y1 - 2016/12/1

N2 - After prompt diagnosis, severe myasthenia gravis and Guillain-Barré syndrome (GBS) usually require management in the intensive care unit. In the myasthenic patient, recognition of precipitating factors is paramount, and frequent monitoring of bulbar, upper airway, and/or respiratory muscle strength is needed to identify impending myasthenic crisis. Noninvasive ventilation can be attempted prior to intubation and mechanical ventilation in the setting of respiratory failure. Cholinesterase inhibitors should be discontinued, but resumed prior to extubation, and steroid dosage could be increased once the airway is secured. In GBS, hemodynamic and respiratory monitoring are essential; however, respiratory failure can develop rapidly and intubation with mechanical ventilation is often required and can be prolonged. Guillain-Barré syndrome can also be complicated by dysautonomia necessitating specific therapies. Prompt recognition and initiation of immunotherapy including intravenous immunoglobulin or plasmapheresis, together with supportive care including treatment of underlying infections and physical therapy, can improve outcomes in both myasthenic crisis and GBS.

AB - After prompt diagnosis, severe myasthenia gravis and Guillain-Barré syndrome (GBS) usually require management in the intensive care unit. In the myasthenic patient, recognition of precipitating factors is paramount, and frequent monitoring of bulbar, upper airway, and/or respiratory muscle strength is needed to identify impending myasthenic crisis. Noninvasive ventilation can be attempted prior to intubation and mechanical ventilation in the setting of respiratory failure. Cholinesterase inhibitors should be discontinued, but resumed prior to extubation, and steroid dosage could be increased once the airway is secured. In GBS, hemodynamic and respiratory monitoring are essential; however, respiratory failure can develop rapidly and intubation with mechanical ventilation is often required and can be prolonged. Guillain-Barré syndrome can also be complicated by dysautonomia necessitating specific therapies. Prompt recognition and initiation of immunotherapy including intravenous immunoglobulin or plasmapheresis, together with supportive care including treatment of underlying infections and physical therapy, can improve outcomes in both myasthenic crisis and GBS.

KW - acute inflammatory demyelinating polyradiculo-neuropathy

KW - Guillain-Barré syndrome

KW - myasthenia gravis

KW - myasthenic crisis

KW - neurocritical care

UR - http://www.scopus.com/inward/record.url?scp=85000394607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000394607&partnerID=8YFLogxK

U2 - 10.1055/s-0036-1592106

DO - 10.1055/s-0036-1592106

M3 - Article

C2 - 27907966

AN - SCOPUS:85000394607

VL - 36

SP - 615

EP - 624

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 6

ER -